Brucellosis is an infectious disease caused by bacteria from the Brucella genus that can be transmitted to humans through contact with infected animals or contaminated animal products. Brucellosis also causes financial losses in animal production. Ruminants are highly susceptible to brucellosis, and the causative agent water buffaloes (Bubalus bubalis) is Brucella abortus. Circulating microRNAs (miRNAs) are cropping up as promising biomarkers for several infectious diseases. the goals of this study were to characterize the serum miRNA signature associated with brucellosis in water buffaloes and investigate the miRNAs' potential use as biomarkers in vaginal fluids. Next Generation Sequencing was used to assess miRNA expression profiles in Brucella-positive and Brucella-negative blood sera; dysregulated miRNAs in blood serum and vaginal fluids were validated using RT-qPCR. ROC curves were generated to evaluate the diagnostic value of miRNAs for Brucella. Go and KeGG pathway enrichment analyses were exploited to investigate the biological functions of dysregulated miRNAs. The results showed that 20 miRNAs were modulated, of which, 12 were upregulated and 8 were downregulated. These findings were corroborated by RT-qPCR, and ROC curves indicated that the miRNAs can serve as potential biomarkers for Brucella. Go and KeGG pathway analyses pointed out that some of these miRNAs are related to immune response and apoptosis. these results provided an overview of miRNA expression profiles and highlighted potential biomarkers for Brucella infection in water buffaloes. We also demonstrated the potential of vaginal fluids in studies involving microRNA detection. Further functional and mechanistic studies of these miRNAs may improve our understanding of the biological processes involved in Brucella infection and host immune response.
Results
Identifying differentially expressed serum microRNAs during B. abortus infection by miRNA sequencing. Serum miRNAs were sequenced to determine the differential miRNA profiles of B. abortus-infected and healthy buffaloes. A total of 469 miRNAs were identified, of which, 20 showed significantly altered expression in seropositive animals compared with seronegative animals. In seropositive animals, the expressions of 12 miRNAs were upregulated 1.8-to 3.7-fold, while 8 miRNAs were downregulated 1.8-to 6.7-fold (P ≤ 0.05) ( Table 1) . Validating microRNA sequencing results and quantifying differentially expressed miRNAs in blood serum and vaginal fluid samples. qPCR validation was performed on the 30 sequenced samples and a separate independent cohort of 30 buffaloes. To validate the sequencing results, 12 differentially expressed (DE)-miRNAs were selected, and their relative abundance was quantified using RT-qPCR. MiRNA levels were normalized to that of cel-miR-39, an artificial spike-in which was used as an internal control. The selected miRNA targets were detected in all blood serum and vaginal fluid samples. RT-qPCR results for the blood serum demonstrated that the levels of four miRNAs (miR-320a, miR-133a, miR-92a, and miR-221) were significantly downregulated in seropositive buffaloes ( Fig. 1 ). An analysis of 12 selected miRNAs from the vaginal fluid demonstrated that 10 miRNAs (miR-let-7i, miR-150, miR-320a, miR-191, miR-let-7f, miR-339b, miR-30e, miR-151, miR-126-5p, and miR-92a) were significantly differentially expressed between Brucella-positive and negative buffaloes. Figure 2 presents an overview of these results. DE-miRNA levels were unaffected by the animals' oestrus phases (linear regression, P > 0.05).
Assessing the diagnostic value of De-miRNAs during B. abortus infection.
To analyse the diagnostic value of DE-miRNAs in the blood serum and vaginal fluid, ROC curves were analysed, and the associated area under the curve (AUC) was used to confirm the diagnostic potency of each miRNA. The ROC was analysed as previously reported 22 . Table 2 summarizes the diagnostic performance of each DE-miRNA and shows combinations of some DE-miRNAs. The AUC was fair for blood serum miR-320a and miR-92a and poor for blood serum miR-133a and miR-221 (Supplemental Material 1). The AUC was excellent for vaginal fluid miR-151 and miR-30e, with calculations of 0.957 and 0.931, respectively; good for miR-let-7f, miR-339b, miR-150 and miR-191 (AUC ≥ 0,799); fair for miR-let-7i, miR-92a and miR-320a; and poor for miR-126-5p ( Fig. 3 ). To test potential collinearity, a Spearman correlational analysis was performed on the vaginal fluid miRNAs with excellent and good AUC values, suggesting that relative concentrations of miR-151, miR-339b, miR-150, miR-191, and miR-30e are positively correlated with each other (data not shown). Discriminant analysis was applied to further investigate the potential for improving diagnostic performance by analysing multiple DE-miRNAs. Statistical analysis was performed examining the weighted average relative quantification (RQ) values of the miRNAs with an AUC > 0.7 for serum blood (miR-320a and miR-92a) and AUC > 0.8 for vaginal fluid (miR-let-7f, miR-151, miR-30e, miR-191, miR-150 and miR-339b) ( Fig. 4 ). Median expression levels in the blood sera were 0.649 (range, 0.229 to 1.639) and 0.542 (range, 0.188 to 1.889) and in the vaginal fluid 11.62 (range, −6.6 to 40.36) and −6.16 (range, −67.6 to 73.8) in Brucella-positive and Brucella-negative buffaloes, respectively ( Fig. 4A,C) . The predicted probability of being discriminated as positive from the logit model based on the two blood sera [logit = (0.6045 × expression level of miR-320a) + (0.4045 × expression level of miR-92a)] or the six vaginal fluid miRNAs [logit = (0.936 × expression level of let-7f) + (4.183 × expression ] was used to construct the ROC curves ( Fig. 4C,D) . The AUC for the combined blood serum miRNAs was 0.753 (95% CI 0.620-0.857) with a cut-off value of 0.90 and 80% sensitivity and 56.25% specificity. The AUC for the combined vaginal fluid miRNAs was 0.88 (95% CI 0.742-0.959) with a cut-off value of 0.023 and 95.45% sensitivity and 85% specificity. Clustering patterns were further visualized using multidimensional scaling plots (MDS) ( Fig. 5 ). These plots generate distances between samples corresponding to the biological coefficient of variation between miRNAs in each sample. The MDS plots comparing seropositive and seronegative buffaloes showed distinct groupings of infected and control animals in both the blood serum and vaginal fluid samples, highlighting a clear miRNA expression distinction by infection type.
miRNA target prediction and pathway enrichment. Predicted significant DE-miRNA targets were computationally fetched from the TargetScan database, and genes with cumulative weighted context++ scores (CWCS) < −0.4 were further analysed. mRNA was enriched using DAVID bioinformatics to explore the function and pathogenesis of these candidate biomarkers. Gene Ontology (GO) analysis was performed using DAVID at three levels: Molecular Function (MF), Cellular Component (CC) and Biological Process (BP). Figure 6A illustrates the top 10 items that were significantly enriched by target genes for each of the above GO levels. The enriched GO terms in MF mainly included protein binding and kinase activities. The CC items in which the predicted targets were involved were related to proteins involved in structure (nucleus and cytoplasm) and function 
Discussion
Although serum circulating miRNAs are some of the most promising clinical diagnostic or therapeutic biomarkers for diagnosing various diseases and stress disorders in both humans 33 and animals 22, 23 , their diagnostic potential in veterinary medicine remains to be fully explored.
To the best of the authors' knowledge, the present study is the first to address the relationship between Brucella infection and miRNAs in dairy water buffaloes. We adopted a multistep approach, using miRNomics as a first step to identifying differentially expressed miRNAs in blood serum, then validated them in blood serum and vaginal fluid, which was shown to be a reliable source of microRNA for the first time. We selected vaginal fluid as a potential miRNA source because the reproductive system is the preferential target organ for Brucella infection. We found that (I) the levels of four miRNAs were significantly downregulated in the blood serum of seropositive buffaloes; (II) the levels of 10 miRNAs were significantly higher in the vaginal fluids of seropositive than in seronegative animals; (III) diagnostic accuracy for B. abortus was excellent (0.90 < AUC < 1) for two miRNAs (miR-151 and miR-30e) and good (0.80 < AUC < 0.90) for four miRNAs (miR-let-7f, miR-339b, miR-150 and miR-191); and (IV) the diagnostic accuracy of the combination of six differentially expressed miRNAs was good (AUC = 0.88) with 95.45% sensitivity and 85% specificity. We also demonstrated that miRNAs can be efficiently extracted from vaginal fluids.
Sequencing results provided a list of differentially abundant miRNAs but validation with RT-qPCR demonstrated that the differential expression rate in the serum between Brucella-seropositive and seronegative animals was not statistically significant. Therefore, the results suggested that miRNA expression levels were similar in the blood sera of seropositive and seronegative water buffaloes. Nevertheless, technical bias inherent in sequencing technologies may generate distorted results. A substantial distortion between miRNA levels in NGS data and true miRNA abundancy may occur using Illumina sequencing technology 34 . Because vaginal fluids may express the same miRNAs as in the serum during B. abortus infection 35 , these miRNAs were quantified, and the results are promising.
In addition to well-established tests, such as serological and microbiological tests, a molecular approach was used to broadly assess Brucella spp. infections [36] [37] [38] . MiRNAs regulate gene expression in many pathophysiological pathways, including those involved in microbial infection. Changes in host miRNA expression occur following infection with exclusively extracellular (Helicobacter pylori) or intracellular (Salmonella enterica) gram-negative bacteria, as well as in response to gram-positive bacteria (Listeria monocytogenes) and other pathogens (Mycobacterium and Francisella species) 17, 39 . The infected cells modulate miRNAs, suppressing host immune responses and promoting microbial pathogenesis. For example, let-7 family miRNAs, which were upregulated in the present study, are involved in modulating two major cytokines, IL6 and IL10, which have opposite effects on the immune response: specifically IL6 promotes, whereas IL10 dampens the proinflammatory programme. The miR-150 family (both miR150 and miR-151 were downregulated in the present study) is involved in lymphocyte development and regulation; a recent study identified that serum circulating miR-150 is a general lymphocyte activation sensor and may serve as a biomarker for human lymphocyte activation in healthy and diseased conditions 40 . The miR-30 family, to which miR-30e belongs and which was downregulated in the present study, is involved in modulating host SUMOylation by downregulating UBC9, a protein involved in T cell development 41 . The results reported herein suggest that B. abortus may influence the immune responses of infected buffaloes by modulating the production and exocytosis of miRNAs that influence both innate and adaptive immune responses, potentially acting on phagocytic cells and lymphocytes as previously suggested for cattle 42 . Accurate screening tests are important for the success of brucellosis eradication programmes. This study suggests that vaginal DE-miRNA levels accurately differentiated B. abortus-infected buffaloes from controls. Many miRNAs aberrantly expressed mRNAs have been identified between Brucella-infected and noninfected buffaloes, and the relative expressions of DE-miRNAs, such as miR-151 and miR-30e, were used to discriminate seropositive vs seronegative animals. These miRNAs had high sensitivity (>94%) up to 100% for miR-151, but low specificity, which reached 85% when some of these were combined. These data showed that miRNAs collected from vaginal fluids may be suitable for use in screening because they can solve many problems that arise from other tests 14, 15 . The sensitivity and specificity of the immunological tests used to routinely diagnose brucellosis in cattle have been summarized by several authors 16, 43, 44 who believe that more than one test should be applied to serologically diagnose brucellosis in the field. The main issue concerns test sensitivity, which normally does not exceed 90%, whereas specificity can reach 100%. Quantifying a panel of miRNAs in the vaginal fluid increases sensitivity to 95% with an adequate 85% specificity. The authors believe that applying this miRNA panel may help to identify infected animals, particularly in extensive breeding systems where brucellosis is endemic or transmission is relatively low. Combining immunological and molecular tests may enable an ideal balance between specificity and sensitivity. Our results suggest that noninvasive molecular biomarkers may help to more accurately assess and monitor Brucella infections. Gene Ontology analysis demonstrated that DE-miRNAs regulated mRNA coding for proteins involved in several molecular functions, cellular components and biological processes involved in Brucella pathogenesis. For example, these DE-miRNAs may target genes coding for G-proteins, plasma membranes and membrane rafts, which are essential for Brucella endocytosis, highlighted at the CC and MF levels. The pivotal role of these mechanisms was elucidated by Rossetti and colleagues 45 , who demonstrated that pathogens attaching to the cell surface induce a zipper-like mechanism for internalization, and binding activates the GTPases, promoting cytoskeleton reorganization and thus host cell membrane rearrangement. Inside cells, these pathogens reside in the Brucella-containing vacuole (BCV) and influence two other processes potentially targeted by DE-miRNAs: the inflammatory reaction, which is modulated by T4SS (type IV secretion system) 46 , and changes in host cell transcription processes 47 . PI3K (phosphatidylinositol 3-kinase) activities, highlighted by both GO and KEGG analysis, 
Animal husbandry, sample collection and oestrus phase classification. Blood and vaginal fluid samples
were collected from 60 buffaloes (Bubalus bubalis) raised on 3 farms in the Caserta area in June and July 2016 during routine national brucellosis prophylaxis programme screening. Animals were housed in an open yard breeding system. Blood was collected by tail venepuncture in serum and Monovette EDTA tubes (Sarstedt Company, Nümbrecht, Germany) and centrifuged at 800 × g for 15 min. Serum and plasma were stored at −80 °C. To collect the vestibulovaginal fluid swabs, the buffaloes were restrained and a sterile swab (sterile swab on a wooden stick with a cotton tip in a polypropylene test tube (12 × 150 mm), FL Medical s.r.l. Unipersonale Padova, Italy) was introduced into the cranial vagina. The swab was exposed to the vestibule-vaginal fluid, pulled inside the pipette and stored at −80 °C.
Oestrous cycle stage was determined by progesterone (P4) [52] [53] [54] and oestradiol (E2) 55 plasma concentrations using radioimmune assays (RIA).
serological and bacteriological analysis. Serology for brucellosis was performed using the Rose-Bengal and complement fixation tests on all samples, as recommended by the World Organization for Animal Health (OIE) Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2017 (version adopted in May 2016) 56 . Microbiological analysis was performed as previously reported by O'Grady and colleagues 57 .
MiRNA extraction, library preparation, and sequencing. Total RNA was extracted using the miR-Neasy Serum/Plasma Kit (Qiagen, catalogue number 217184, Milan, Italy). Serum was thawed on ice and centrifuged at 3000 × g for 5 min at 4 °C. An aliquot of 200 μl per sample was transferred to a new tube, and RNA was µl RNase Inhibitor (20 U/µl), 6 μl of custom RT primer pool and 3.01 μl of nuclease-free water. The custom RT primer pool was prepared by combining 10 µl of each 5× RT primer in a final volume of 1000 µl; the final concentration of each primer in the RT primer pool was 0.05× each. Three μl of serum RNA was added to each RT reaction. Each RT reaction mixture was incubated on ice for 5 min, 16 °C for 30 min, 42 °C for 30 min and 85 °C for 5 min.
To validate the sequencing results, the qPCR experiments were designed following MIQE guidelines 59 . Small RNA TaqMan assays were performed per the manufacturer's instructions using the selected primer/probe assays (ThermoFisher Scientific, Monza, Italy) reported in Table 3 . Quantitative reactions were performed in duplicate in scaled-down (12 μl) reaction volumes using 6 μl TaqMan 2X Universal Master Mix II (ThermoFisher Scientific, Monza, Italy, catalogue number 4440044), 0.6 μl miRNA specific TaqMan Assay 20× and 1μl of the RT product per reaction on the Eco Real-Time PCR detection system (Illumina, Milan, Italy). The standard cycling programme was 50 °C for 2 min, 95 °C for 10 min and 40 cycles at 95 °C for 15 sec and 60 °C for 60 sec. Data were normalized relative to the cel-miR-39 expression. MiRNA expression levels are presented as fold changes normalized to cel-miR-39 expression using the 2 − ΔΔCq formula. The significant miRNA targets were determined using the TargetScan database (http://www.targetscan. org/vert_71/), functional mRNA were enriched using DAVID bioinformatics resources (https://david.ncifcrf.gov/), and biological pathways in KEGG were examined for enrichment (http://www.genome.jp/kegg/). statistical analysis. Statistical analysis was performed using XLStat for Windows (Addinsoft, New York, U.S.A.) and MedCalc 14.0 (MedCalc Software bvba, Ostend, Belgium). Statistical significance was accepted at P < 0.05. Data were tested for normality and homogeneity of variance using the Kolmogorov-Smirnov and Levene tests, respectively. Because the data were not normally distributed, nonparametric statistical tests were applied. The Kruskal-Wallis test was used to assess differences in miRNA concentrations. P values were adjusted using the Bonferroni correction. Linear regression was used to investigate relationships between DE-miRNAs and oestrus phases. Receiver operating characteristic (ROC) analysis was performed to determine the diagnostic accuracy of targets that statistically differed between Brucella-positive and negative animals. The diagnostic values were calculated for miRNAs that showed significant differential expression in the buffalo blood. Distance matrices were processed by multidimensional scaling (MDS) to obtain a dimensionally reduced map of the miRNA coordinates. Linear regression was used to investigate relationships between miRNAs and the buffaloes' ages. Spearman's Rho test was performed to evaluate whether the expression levels of the various miRNAs were correlated. 
